Latest Advanced Prostate Cancer News2017-10-19T10:43:14-04:00

One Third of All Cancer Survivors Fail to Have any Conversations with their Healthcare Providers about their Psychosocial Issues

Not terribly surprising, but recent research shows that less than one-third of all cancer survivors of adult cancers in the United States ever had conversations with their healthcare providers about their psychosocial needs. The latest [...]

Senate Appropriations Subcommittee on Defense Increases FY14 DOD Budget Markup

The US Senate Appropriations Subcommittee on Defense yesterday marked-up their version of the FY14 Defense Appropriations Act. The full committee is scheduled to mark up tomorrow Thursday). The following is an excerpt from the committee’s [...]

By |July 31st, 2013|Categories: Advanced Prostate Cancer, Advocacy, DOD, Financial, Research, Uncategorized|Tags: , |0 Comments

Understanding & Treating Radiation Proctitis Resulting from Prostate Cancer Treatment

One of the more common side effects of primary prostate cancer treatment with any form of x-ray or ionizing radiation is known as radiation proctitis and the related radiation colitis. Radiation proctitis is inflammation and [...]

Takeda Un-blinds & Halts the Phase 3 Study of Orteronel in Men with mCRPC That Progressed Post-Chemotherapy

A press release made yesterday brought some bad news to the advanced prostate cancer community. Takeda Pharmaceutical Company Limited (“Takeda”) announced that it has un-blinded and stopped the ELM-PC 5 Phase 3 study (C21005) of [...]

DOD Gets a Thumbs Up From Congress for FY14 – Some Great News

Yesterday we did have some good news for cancer survivors which didn’t get any significant attention. Most of the media attention from yesterday’s congressional budget vote was focused on an amendment dealing with NSA surveillance, [...]

Go to Top